IVD Advice for Experienced Manufactures
May 23, 2022
Listen to Dr. Peter Wirthschaft, Senior Manager for IVD Consulting, EMEA, for practical advice that goes beyond the basics.
Ready To Begin the Process
Peter talks about how to deal with significant changes to products during the transition period, how to make OEM products ready for IVDR, how to streamline clinical performance evaluation and what to do with incomplete technical files. Remember:
- Prioritize products that will have significant changes to design or intended purpose.
- Have a quality assurance agreement in place with your OEM to determine who owns the technical documentation and start with a pilot project to establish procedures.
- Consolidating all your clinical or performance data into a performance evaluation report will help with ongoing updating during the product lifecycle (see Annex VIII 1.3.2).
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.